Adenovirus Diagnostic Testing Market Moving Toward 2026 With New Procedures
Adenovirus is one of the DNA viruses that are considered to be a major cause of febrile illness, primarily among children. Individuals and Infants with weak immune systems, cardiac disease or chronic respiratory problems are at higher risk of developing adenovirus infection, however, most infections are not severe. Adenovirus is a communicable infection, as it is an air-borne diseases and can spread from infected person to others by coughing and sneezing, and close contact such as shaking or touching hands.
Request For a Sample Copy of This Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/1678
Adenovirus can cause pneumonia, acute respiratory disease, epidemic kerato-conjunctivitis, acute follicular conjunctivitis, gastroenteritis, and cystitis. Among infants, pharyngeal-conjunctival and pharyngitis fever are commonly caused by Adenovirus. In 2016, a study conducted by Barcelona Center for International Health Research and University of Barcelona, on children suffering from pneumonia, suggests that adenovirus is the second-most common respiratory virus causing pneumonia. Some adenoviruses can also spread through the infected person’s stools, for instance, during diaper changing. Adenovirus can also spread through water such as swimming pools, however, this is less common. Adenovirus infections can be usually diagnose by molecular methods or can be detected with polymerase chain reaction (PCR), serology, antigen detection or viral culture. Others emerging technologies such as liposomes, monoclonal antibodies, chromatography, flow cytometry, and gel micro droplets are also of vital use in diagnosis of adenovirus infection.
Adenovirus Diagnostic Testing Market – Driver
Adenoviruses are associated with a variety of nonspecific manifestations and clinical syndromes, thus diagnosis based upon clinical criteria alone is challenging. Diagnosis is most accurate when the infection shows outbreak symptoms or individuals show serious disease manifestations. Validation of adenovirus infection is essential for identifying the most appropriate treatment to establish a prognosis and initiate infection control measures by using correct antiviral agents, thus making diagnosis of these viruses a vital procedure. This in turn, is expected to augment growth of the adenovirus diagnostic testing market. Generally, there are two types of adenoviruses namely, Type 4 and Type 7 that caused severe outbreaks of respiratory illness, especially among military recruits.
Adenovirus Diagnostic Testing Market – Competitive Landscape
Player operating in the adenovirus diagnostic testing market include Affymetrix, Inc., Becton Dickinson and company, F. Hoffmann-La Roche AG, Bio-Rad Laboratories Inc., Novartis AG, Qiagen N.V., DiaSorin Inc., Abbott Laboratories, and bioMerieux.
Purchase This Premium Report @ https://www.coherentmarketinsights.com/insight/buy-now/1678
Adenovirus Diagnostic Testing Market – Taxonomy
By Assay Type
- PCR Assay Kits
- Antigen Detection Kits
- Other Assay Kits
By End User
- Diagnostic Laboratories
Adenovirus Diagnostic Testing Market – Regional Analysis
Geographically, the global Adenovirus Diagnostic Testing Market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. The market in North America is expected to gain significant traction, owing to growing public health concerns regarding various infectious diseases such as pneumonia, which are associated with adenovirus infection. For instance, in 2014, the eighth cause of mortality in the U.S. was influenza and pneumonia together, as reported by the National Centre for Health Statistics. The adenovirus diagnostic testing market is expected to gain traction in Africa markets, where a large number of children infected with adenovirus are underserved.